Poultry Pharmaceuticals Market, By Product Type (Drugs (VETRIMOXIN, Other Drug Products), Vaccines (INNOVAX, NOBILIS, Poulvac, Other Vaccine Products), Feed Additives (VIGOSINE, Amnovit, Other Feed Additives)), By Animal Type (Chicken, Turkey, Duck, Goose

Poultry Pharmaceuticals Market, By Product Type (Drugs (VETRIMOXIN, Other Drug Products), Vaccines (INNOVAX, NOBILIS, Poulvac, Other Vaccine Products), Feed Additives (VIGOSINE, Amnovit, Other Feed Additives)), By Animal Type (Chicken, Turkey, Duck, Goose, Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. For instance, according to Poultry Hub, an initiative of Poultry Hub Australia, worldwide poultry production was around 111,000 thousand metric tons in 2015 and is expected to reach 131,255 thousand metric tons by 2025, exhibiting a CAGR of 24% over the forecast period (2019 to 2027). Several poultry diseases are responsible for loss of poultry products which can be prevented by use of pharmaceutical products.

Restraints of the Global Poultry Pharmaceuticals Market
Major factors hampering the growth of the poultry pharmaceuticals market during the forecast period constitutes of low product exclusivity, generic competition, and stringent regulations. Product exclusivity period is only three to five years in the animal health care industry.
Key features of the study:
This report provides in-depth analysis of the global poultry pharmaceuticals market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global poultry pharmaceuticals market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Poultry Pharmaceuticals Market, By Product Type:
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
Global Poultry Pharmaceuticals Market, By Animal Type:
Chicken
Turkey
Duck
Goose
Others
Global Poultry Pharmaceuticals Market, By Geography:
North America
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country:
U.S.
Canada
Europe
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type
Drugs
VETRIMOXIN
Other Drug Products
Vaccines
INNOVAX
NOBILIS
Poulvac
Other Vaccine Products
Feed Additives
VIGOSINE
Amnovit
Other Feed Additives
By Animal Type:
Chicken
Turkey
Duck
Goose
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Bayer AG*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Bimeda
Ceva Sante Animale
Elanco Animal Health (Eli Lilly and Company)
Merck Animal Health
Merial Animal Health (Sanofi)
Virbac
Boehringer Ingelheim
Zoetis, Inc.
Pacific GeneTech
Avivagen Inc.
“*” marked represents similar segmentation in other categories in the respective section.